Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 507Uterine Cervical Neoplasms 361Endometrial Neoplasms 304Breast Neoplasms 128Colorectal Neoplasms 112Neoplasms 98Fallopian Tube Neoplasms 90Carcinoma, Non-Small-Cell Lung 87Stomach Neoplasms 83Pancreatic Neoplasms 79Lung Neoplasms 72Melanoma 68Prostatic Neoplasms 66Carcinoma, Ovarian Epithelial 65Neoplasm Metastasis 63Triple Negative Breast Neoplasms 51Vulvar Neoplasms 49Squamous Cell Carcinoma of Head and Neck 49Head and Neck Neoplasms 45Esophageal Neoplasms 43Uterine Neoplasms 40Peritoneal Neoplasms 40Urinary Bladder Neoplasms 38Carcinoma, Hepatocellular 35Carcinoma, Renal Cell 34Uterine Cervical Dysplasia 31Papillomavirus Infections 31Colonic Neoplasms 31Sarcoma 30Recurrence 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gallstones × Gynecologic × Clear all
NCT07480785 2026-03-18

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

Zhejiang University

Phase NA Recruiting
780 enrolled
Gynecologic

Leiomyoma, Ovarian Neoplasms, Postoperative Nausea and Vomiting, Gallstones

Data powered by HemOnc (CC BY 4.0) Colophon âš¡